Recordati Industria Chimica e Farmaceutica S.p.A.

Milan Stock Exchange REC.MI

Recordati Industria Chimica e Farmaceutica S.p.A. Free Cash Flow Yield on January 14, 2025: 0.99%

Recordati Industria Chimica e Farmaceutica S.p.A. Free Cash Flow Yield is 0.99% on January 14, 2025, a 0.10% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Recordati Industria Chimica e Farmaceutica S.p.A. 52-week high Free Cash Flow Yield is 1.06% on June 17, 2024, which is 7.36% above the current Free Cash Flow Yield.
  • Recordati Industria Chimica e Farmaceutica S.p.A. 52-week low Free Cash Flow Yield is 0.92% on October 17, 2024, which is -7.46% below the current Free Cash Flow Yield.
  • Recordati Industria Chimica e Farmaceutica S.p.A. average Free Cash Flow Yield for the last 52 weeks is 0.99%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Loading...
Milan Stock Exchange: REC.MI

Recordati Industria Chimica e Farmaceutica S.p.A.

CEO Dr. Robert Koremans M.D.
IPO Date March 28, 1995
Location Italy
Headquarters 1, Via Matteo Civitali
Employees 4,450
Sector Health Care
Industries
Description

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.

Similar companies

CPR.MI

Davide Campari-Milano N.V.

USD 5.59

-2.10%

AMP.MI

Amplifon S.p.A.

USD 26.82

1.34%

BRE.MI

Brembo S.p.A.

USD 8.91

-0.66%

DIA.MI

DiaSorin S.p.A.

USD 103.47

-0.44%

PRY.MI

Prysmian S.p.A.

USD 65.92

0.76%

StockViz Staff

January 15, 2025

Any question? Send us an email